home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 09, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday? ↗

September 09, 2024

U.S. stocks started the new week with strong gains, as all major indices and sectors in the S&P 500 were in the green by midday in New York. This comes after Wall Street experienced its worst week of...

Via Benzinga

Topics Stocks

Why Is Moderna Stock Trading Higher On Monday? ↗

September 09, 2024

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vaccines domestically by 2025. The site will manufacture COVID-19, RSV, and flu...

Via Benzinga

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

September 09, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

A Closer Look at Moderna's Options Market Dynamics ↗

September 09, 2024

Via Benzinga

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

September 09, 2024

Via ACCESSWIRE

Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio? ↗

September 08, 2024

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.

Via Benzinga

Is It Time to Buy August's Worst-Performing Nasdaq Stocks? ↗

September 07, 2024

These tech stocks got hit hard last month. Should you buy the dip?

Via The Motley Fool

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows ↗

September 06, 2024

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.

Via Benzinga

Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy ↗

September 05, 2024

The "Mad Money" host said Oklo Inc. is a company that is again losing so much money "I can't even look at it."

Via Benzinga

Smart Money Is Betting Big In MRNA Options ↗

September 04, 2024

Via Benzinga

Wellness In Your Personal Life Unleashes Productivity At Work ↗

August 30, 2024

Our world is obsessed with individual productivity.

Via Investor's Business Daily

Moderna Unusual Options Activity ↗

August 27, 2024

Via Benzinga

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

September 05, 2024

Via ACCESSWIRE

Moderna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company – Seek Counsel Today

September 04, 2024

From Robbins LLP

Via GlobeNewswire

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Is It Time to Buy August's Worst-Performing S&P 500 Stocks? ↗

September 04, 2024

What happened to August's worst-performing stocks? Discover if these underperformers from the famous S&P 500 index are potential buys or value traps.

Via The Motley Fool

Topics Stocks

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

September 03, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

UK, Taiwan Approve Moderna's Updated COVID-19 Shot ↗

September 03, 2024

The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 variant, available for eligible groups through the NHS autumn program and for...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 03, 2024

Via Benzinga

Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1

September 03, 2024

Via ACCESSWIRE

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 03, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

September 02, 2024

Via ACCESSWIRE

Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗

August 31, 2024

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

Via Benzinga

Topics Stocks

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

August 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales ↗

August 29, 2024

BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these innovative treatments face challenges in cost, scalability, and...

Via Benzinga

Shareholder Rights Law Firm Robbins LLP Urges Moderna, Inc. Stockholders to Seek Counsel for the MRNA Class Action

August 28, 2024

From Robbins LLP

Via GlobeNewswire

This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗

August 28, 2024

Via Benzinga

Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential ↗

August 27, 2024

PDD Holdings Inc. (NASDAQ: PDD) saw a 29% drop after disappointing Q2 results, but analysts remain bullish with price targets ranging from $84 to $185.

Via Benzinga

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com